TrivarX Limited (MDBIF)

OTCMKTS · Delayed Price · Currency is USD
0.0021
-0.0048 (-69.57%)
At close: Dec 19, 2024
-86.00%
Market Cap 4.38M
Revenue (ttm) 1.24M
Net Income (ttm) -272.42K
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 875
Average Volume 9,048
Open 0.0261
Previous Close 0.0069
Day's Range 0.0021 - 0.0261
52-Week Range 0.0021 - 0.0261
Beta 0.88
RSI 40.37
Earnings Date May 29, 2025

About TrivarX

TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia. [Read more]

Sector Healthcare
Founded 1987
Employees 6
Stock Exchange OTCMKTS
Ticker Symbol MDBIF
Full Company Profile

Financial Performance

In 2024, TrivarX's revenue was 888,829, a decrease of -7.46% compared to the previous year's 960,451. Losses were -1.43 million, -53.28% less than in 2023.

Financial numbers in AUD Financial Statements

News

There is no news available yet.